Second Sight Medical Products Inc. (EYES)

0.89
0.04 3.80
NASDAQ : Health Technology
Prev Close 0.93
Open 0.90
Day Low/High 0.88 / 0.91
52 Wk Low/High 0.64 / 1.98
Volume 126.13K
Avg Volume 151.80K
Exchange NASDAQ
Shares Outstanding 124.59M
Market Cap 119.59M
EPS -0.50
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Second Sight To Discuss Second Quarter 2019 Financial Results On August 6, 2019 Conference Call

Second Sight To Discuss Second Quarter 2019 Financial Results On August 6, 2019 Conference Call

Second Sight Medical Products, Inc. (NASDAQ: EYES), a developer, manufacturer and marketer of implantable visual prosthetics intended to create an artificial form of useful vision for blind individuals, will release its financial results for the second...

Researchers Present Latest Positive Results Of Second Sight's Orion Visual Cortical Prosthesis Feasibility Study

Researchers Present Latest Positive Results Of Second Sight's Orion Visual Cortical Prosthesis Feasibility Study

Second Sight Medical Products, Inc. (NASDAQ:EYES) ("Second Sight" or the "Company"), a developer, manufacturer and marketer of implantable visual prosthetics intended to create an artificial form of useful vision for blind individuals, announced that...

Second Sight To Present At 20th Annual B. Riley FBR Investor Conference

Second Sight To Present At 20th Annual B. Riley FBR Investor Conference

Second Sight Medical Products, Inc. (NASDAQ: EYES) ("Second Sight" or the "Company"), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision for blind individuals, announced...

Second Sight Reports First Quarter 2019 Financial Results

Second Sight Reports First Quarter 2019 Financial Results

Second Sight Medical Products, Inc. (NASDAQ:EYES) ("Second Sight" or the "Company"), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision for blind individuals, today...

Second Sight To Accelerate Development Of Orion® Visual Cortical Prosthesis System

Second Sight To Accelerate Development Of Orion® Visual Cortical Prosthesis System

Second Sight Medical Products, Inc. (NASDAQ: EYES) ("Second Sight" or the "Company"), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision for blind individuals, today...

Second Sight To Discuss First Quarter 2019 Financial Results On May 15, 2019 Conference Call

Second Sight To Discuss First Quarter 2019 Financial Results On May 15, 2019 Conference Call

Second Sight Medical Products, Inc. (NASDAQ: EYES), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision for blind individuals, will release its financial results for the...

Second Sight Medical Products, Inc. Presents Positive Interim Results At The Fifth Annual BRAIN Initiative® Investigators Meeting

Second Sight Medical Products, Inc. Presents Positive Interim Results At The Fifth Annual BRAIN Initiative® Investigators Meeting

Second Sight Medical Products, Inc. (NASDAQ: EYES) ("Second Sight" or the "Company"), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision for blind individuals, today...

Second Sight Reports Fourth Quarter And Full Year 2018 Financial Results

Second Sight Reports Fourth Quarter And Full Year 2018 Financial Results

Second Sight Medical Products, Inc. (NASDAQ: EYES) ("Second Sight" or the "Company"), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision for blind individuals, today...

Second Sight To Discuss Fourth Quarter And Year-End 2018 Financial Results On March 13, 2019 Conference Call

Second Sight To Discuss Fourth Quarter And Year-End 2018 Financial Results On March 13, 2019 Conference Call

Second Sight Medical Products, Inc. (NASDAQ:EYES), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision to blind patients, will release its 2018 fourth quarter and...

Second Sight Medical Products, Inc. Announces Completion Of Rights Offering

Second Sight Medical Products, Inc. Announces Completion Of Rights Offering

Second Sight Medical Products, Inc. (NASDAQ: EYES) ("Second Sight" or the "Company"), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision for blind individuals, today...

Second Sight To Discuss Third Quarter 2018 Financial Results On November 7, 2018 Conference Call

Second Sight To Discuss Third Quarter 2018 Financial Results On November 7, 2018 Conference Call

Second Sight Medical Products, Inc. (NASDAQ: EYES), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision to blind individuals, will release its 2018 third quarter...

Second Sight Completes $4 Million Private Placement Of Common Stock With Gregg Williams, Chairman Of The Board Of Directors

Second Sight Completes $4 Million Private Placement Of Common Stock With Gregg Williams, Chairman Of The Board Of Directors

Second Sight Medical Products, Inc. (NASDAQ: EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision to blind individuals, today...

Second Sight Receives $1.6 Million Grant From National Institutes Of Health To Support Orion Clinical Development

Second Sight Receives $1.6 Million Grant From National Institutes Of Health To Support Orion Clinical Development

Second Sight Medical Products, Inc. (NASDAQ: EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision to blind individuals, today...

Second Sight Appoints Pat Ryan Chief Operating Officer

Second Sight Appoints Pat Ryan Chief Operating Officer

Second Sight Medical Products, Inc. (NASDAQ:EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision to blind patients, announced...

Second Sight To Present At Investor Conferences In September

Second Sight To Present At Investor Conferences In September

Second Sight Medical Products, Inc. (NASDAQ:EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision to blind patients, today...

Second Sight Completes $5.0 Million Private Placement Of Common Stock With Gregg Williams, Chairman Of The Board Of Directors

Second Sight Completes $5.0 Million Private Placement Of Common Stock With Gregg Williams, Chairman Of The Board Of Directors

Second Sight Medical Products, Inc. (NASDAQ: EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision to blind patients, today...

Second Sight Reports Second Quarter 2018 Financial Results

Second Sight Reports Second Quarter 2018 Financial Results

Second Sight Medical Products, Inc. (NASDAQ:EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision to blind patients, today reported...

Second Sight To Discuss Second Quarter 2018 Financial Results On August 7, 2018 Conference Call

Second Sight To Discuss Second Quarter 2018 Financial Results On August 7, 2018 Conference Call

Second Sight Medical Products, Inc. (NASDAQ:EYES), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision to blind patients, will release its 2018 second quarter financial...

Second Sight Medical Products, Inc. To Present At The 19th Annual B. Riley FBR Investor Conference

Second Sight Medical Products, Inc. To Present At The 19th Annual B. Riley FBR Investor Conference

Second Sight Medical Products, Inc. (NASDAQ: EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision to blind patients, today...

Second Sight Reports First Quarter 2018 Financial Results

Second Sight Reports First Quarter 2018 Financial Results

Second Sight Medical Products, Inc. (NASDAQ:EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision to blind patients, today reported...

Second Sight Completes $10 Million Private Placement Of Common Stock With Gregg Williams, Chairman Of The Board Of Directors

Second Sight Completes $10 Million Private Placement Of Common Stock With Gregg Williams, Chairman Of The Board Of Directors

Second Sight Medical Products, Inc. (NASDAQ: EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision to blind patients, today...

Second Sight To Discuss First Quarter 2018 Financial Results On May 10, 2018 Conference Call

Second Sight To Discuss First Quarter 2018 Financial Results On May 10, 2018 Conference Call

Second Sight Medical Products, Inc. (NASDAQ: EYES), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision for blind patients, will release its 2018 first quarter financial...

Second Sight Appoints John T. Blake Chief Financial Officer

Second Sight Appoints John T. Blake Chief Financial Officer

Second Sight Medical Products, Inc. (NASDAQ: EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision...

Second Sight Appoints Gregg Williams As Chairman Of The Board Of Directors

Second Sight Appoints Gregg Williams As Chairman Of The Board Of Directors

Second Sight Medical Products, Inc. (NASDAQ: EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision...

Second Sight Medical Products, Inc. To Present At The B. Riley & Co. China Healthcare Investment Partnering Symposium

Second Sight Medical Products, Inc. To Present At The B. Riley & Co. China Healthcare Investment Partnering Symposium

Second Sight Medical Products, Inc. (NASDAQ: EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision...

Second Sight Reports Fourth Quarter And Full Year 2017 Financial Results

Second Sight Reports Fourth Quarter And Full Year 2017 Financial Results

Second Sight Medical Products, Inc. (NASDAQ: EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision...

Second Sight Announces Latest Expansion Of Medicare Coverage For Argus II Retinal Prosthesis System

Second Sight Announces Latest Expansion Of Medicare Coverage For Argus II Retinal Prosthesis System

Second Sight Medical Products, Inc. (NASDAQ:EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics intended to create an artificial form of useful vision for blind...

Second Sight Medical Products, Inc. To Present At The Inaugural LD Micro Virtual Investor Conference On March 7, 2018

Second Sight Medical Products, Inc. To Present At The Inaugural LD Micro Virtual Investor Conference On March 7, 2018

Second Sight Medical Products, Inc. (NASDAQ:EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision...

TheStreet Quant Rating: D- (Sell)